Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model
GHDx Entry last modified on: Jan 31, 2023
HPV vaccines
Dataset Records for HPV vaccines
Displaying 51 - 100 of 382
Vaccination coverage among school children aged 14-15 years in the French department of Sarthe
GHDx Entry last modified on: Mar 14, 2022
Malaysia Health Indicators 2018
Report:
Discharge - Epi surveillance - Inpatient - Outpatient - Subnationally representative - Urban-rural representative
Surveillance of Vaccination Coverage among Adult Populations - United States, 2015
GHDx Entry last modified on: Apr 14, 2022
United States Behavioral Risk Factor Surveillance System 2015
Survey:
Cross-sectional - Household - Individual - Interview - Subnationally representative
Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage
GHDx Entry last modified on: Jan 31, 2023
Loss of chance associated with sub-optimal HPV vaccination coverage rate in France
GHDx Entry last modified on: Mar 14, 2022
New Zealand Health Survey 2014-2015
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
Guyana Multiple Indicator Cluster Survey 2014
Survey:
Cross-sectional - Health facility - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
United States National Health Interview Survey 2014
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
United States Behavioral Risk Factor Surveillance System 2014
Survey:
Cross-sectional - Household - Individual - Interview - Subnationally representative
Human Papillomavirus Vaccine Initiation among 9-13-Year-Olds in the United States
GHDx Entry last modified on: Mar 14, 2022
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2015
GHDx Entry last modified on: Apr 14, 2022
Cost-effectiveness of human papillomavirus vaccination in Germany
GHDx Entry last modified on: Jan 31, 2023
Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain
GHDx Entry last modified on: Jan 31, 2024
Human papillomavirus vaccine uptake in adolescence and adherence to cervical cancer screening in Switzerland: a national cross-sectional survey
GHDx Entry last modified on: Mar 14, 2022
Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study
GHDx Entry last modified on: Mar 14, 2022
Paving pathways: Brazil's implementation of a national human papillomavirus immunization campaign
GHDx Entry last modified on: Apr 14, 2022
Clinical and economic impact of school-based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis
GHDx Entry last modified on: May 30, 2020
Israel National Health Interview Survey 2014-2015
סקר בריאות לאומי בישראל INHIS-3 2013-2015
Survey:
Individual - Interview - Nationally representative
Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage
GHDx Entry last modified on: Jan 31, 2023
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014
GHDx Entry last modified on: Apr 14, 2022
The Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Indonesia
GHDx Entry last modified on: May 30, 2020
Argentinas Successful Implementation Of A National Human Papillomavirus Vaccination Program
GHDx Entry last modified on: Apr 14, 2022
HPV vaccination crisis in Japan
GHDx Entry last modified on: Mar 14, 2022
Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
GHDx Entry last modified on: Mar 14, 2022
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
GHDx Entry last modified on: May 30, 2020
United States National Health and Nutrition Examination Survey 2013-2014
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
GHDx Entry last modified on: Jan 31, 2024
Successive introduction of four new vaccines in Rwanda: High coverage and rapid scale up of Rwandas expanded immunization program from 2009 to 2013
GHDx Entry last modified on: Mar 14, 2022
The Uptake of Human Papillomavirus Vaccine In Irish Schools: The Impact Of Disadvantage
GHDx Entry last modified on: Mar 14, 2022
Dispelling the myth: Exploring associations between the HPV vaccine and inconsistent condom use among college students
GHDx Entry last modified on: Mar 14, 2022
Impact of HPV vaccination with Gardasil® in Switzerland
GHDx Entry last modified on: Jan 31, 2024
HPV and Cervical Cancer Epidemiology - Current Status of HPV Vaccination in India
GHDx Entry last modified on: Mar 14, 2022
Achieving High Adolescent HPV Vaccination Coverage
GHDx Entry last modified on: Apr 14, 2022
Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore
GHDx Entry last modified on: Jan 31, 2023
HPV vaccines: How many doses are needed for protection?
GHDx Entry last modified on: Mar 14, 2022
Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada
GHDx Entry last modified on: Mar 14, 2022
United States National Health Interview Survey 2013
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran
GHDx Entry last modified on: Jan 31, 2023
Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway
GHDx Entry last modified on: Mar 14, 2022
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
GHDx Entry last modified on: Mar 14, 2022
United States Behavioral Risk Factor Surveillance System 2013
Survey:
Cross-sectional - Household - Individual - Interview - Subnationally representative
Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine
GHDx Entry last modified on: May 30, 2020
Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention
GHDx Entry last modified on: Mar 14, 2022
Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys
GHDx Entry last modified on: Apr 14, 2022
Vaccination coverage among adults, excluding influenza vaccination - United States, 2013
GHDx Entry last modified on: Apr 14, 2022
Subscribe